Skip to main content

Table 2 Past 6 month receipt of alcohol treatment medications at baseline and follow-up by treatment group

From: Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trial

Medication, n (%) Integrated stepped alcohol treatment (n = 47) Treatment as usual (n = 46) p value
Any alcohol treatment medicationa
 Baseline 5 (10.6) 10 (21.7) 0.15
 Week 24 8 (17.0) 11 (23.9) 0.41
 Week 52 5 (10.6) 6 (13.0) 0.72
Disulfiram
 Baseline 0 (0) 0 (0) NA
 Week 24 0 (0) 0 (0) NA
 Week 52 0 (0) 0 (0) NA
Acamprosate
 Baseline 0 (0) 0 (0) NA
 Week 24 0 (0) 0 (0) NA
 Week 52 0 (0) 0 (0) NA
Naltrexone
 Baseline 0 (0) 0 (0) NA
 Week 24 1 (2.1) 1 (2.2) 0.99
 Week 52 1 (2.1) 0 (0) 0.99
Topiramate
 Baseline 0 (0) 0 (0) NA
 Week 24 0 (0) 0 (0) NA
 Week 52 0 (0) 0 (0) NA
Baclofen
 Baseline 1 (2.1) 2 (4.4) 0.62
 Week 24 2 (4.3) 2 (4.4) 0.99
 Week 52 2 (4.3) 1 (2.2) 0.99
Gabapentin
 Baseline 4 (8.5) 8 (17.4) 0.20
 Week 24 6 (12.8) 8 (17.4) 0.53
 Week 52 4 (8.5) 5 (10.9) 0.74
  1. aBased on receipt of disulfiram, acamprosate, naltrexone, topiramate, baclofen and/or gabapentin